NOT-AI-21-081: Notice of Early Expiration of NOT-AI-21-067, Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes"

Notice of Early Expiration of NOT-AI-21-067, Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes"

Notice Number:

NOT-AI-21-081

Key Dates

Release Date:

October 19, 2021

Related Announcements

NOT-AI-21-067 - Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes
NOT-AI-21-080 - Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-21-067 - Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes will be rescinded as of October 19, 2021.

In place of NOT-AI-21-067, NIAID has issued NOT-AI-21-080, Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Nasrin Nabavi, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3538
Email: [email protected]

Rahul Gautam Thakar, Ph.D.
National Heart, Lung, And Blood Institute (NHLBI)
Telephone: 301-496-1740
E-mail: [email protected]